earnings digest health abbott laboratories abbott laboratories posted a drop in first quarter profit on acquisition costs while sales of drugs for arthritis and bipolar disorder helped lift revenue results were affected by purchases that have beefed up its drug and medical device businesses and a pending sale that will trim its diagnostics unit shares of the abbott park ill firm fell cents or to &# in p m new york stock exchange composite trading partly because sales of its top drug humira for inflammatory diseases missed forecasts abbott acquired kos pharmaceuticals in december for &# billion and guidant corp s vascular device business for &# billion a year ago it agreed in january to sell some of its diagnostics businesses to general electric co for &# billion 
